Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples